BioSpace News Archive

CMAB Biopharma Inc., a dedicated biologics contract manufacturing and development organization, announced the appointment of Ms. Maggie Chen as the chief financial officer.

Checkmate Pharmaceuticals, Inc., a clinical stage biotechnology company focused on developing proprietary technology to harness the power of the immune system to combat cancer, announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $15.00 per share.

ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX) (TSX-V: EPI), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal third quarter ended June 30, 2020.